Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Weight Loss × Octreotide × Clear all

Phase

Phase NA 2 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 5 Vipoma 4 Carcinoma, Islet Cell 4 Somatostatinoma 3 Neuroendocrine Tumors 3 Intestinal Obstruction 3 Insulinoma 3 Glucagonoma 3 Gastrinoma 3 Carcinoma, Hepatocellular 3 Thymoma 2 Stomach Neoplasms 2 Prostatic Neoplasms 2 Neoplasm Metastasis 2 Meningioma 2 Diarrhea 2 Carcinoma 2 Carcinoid Tumor 2 Adenoma, Islet Cell 2 Weight Loss 1 Waldenstrom Macroglobulinemia 1 Vomiting 1 Recurrence 1 Rectal Neoplasms 1 Primary Inoperable Thymoma 1 Pleural Effusion 1 Pheochromocytoma 1 Peritoneal Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1

Interventions

anamorelin 2 Tirzepatide 1 Octreotide 1 Nutritionists 1 Nutrition Assessment 1 Mirtazapine 1 Flurandrenolone 1 Exercise 1 EOM613 1 Diet, Carbohydrate-Restricted 1 Acetylcysteine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04871204 2024-10-31

OTIS

Karolinska University Hospital

Phase 2 Completed

Gastrointestinal

Esophageal Neoplasms, Stomach Neoplasms, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon ⚡